Telehealth Reimbursement Gaps Hurting Patients

Key Takeaways

A global scoping review found that public telehealth reimbursement models vary dramatically across jurisdictions, with no consistent standard protecting patients from out-of-pocket costs.
Research from Ghana shows that even in mHealth-based telemedicine programs, unclear pricing and reimbursement structures undermine sustainability and patient trust.
Medicaid patients face significant access barriers to specialized care, with a national mystery-caller study revealing that many orthopedic practices do not accept Medicaid, limiting telehealth’s ability to close equity gaps.
Payment-related obstacles remain a leading reason patients with opioid use disorder cannot access or sustain medications, a problem telehealth alone cannot solve without reimbursement reform.
Physical medicine and rehabilitation patients and providers both report that uncertainty about insurance coverage discourages telehealth adoption, even when the technology is available.

The Reimbursement Patchwork: No Two Jurisdictions Agree

**No two jurisdictions reimburse telehealth the same way — and that inconsistency directly determines whether your virtual visit is covered, how much you pay out of pocket, and whether your provider even offers the service in your state or country. **** The reimbursement landscape is less a coherent system than a patchwork of conflicting rules that shift by payer type, geography, and service category, leaving patients to navigate the gaps largely on their own.

A 2025 scoping review examining public reimbursement models across national and subnational jurisdictions found that telehealth payment policies vary dramatically not just between countries, but between regions within the same country — meaning a patient in one state or province may have full coverage for a video visit while a patient two hours away pays entirely out of pocket for the identical service.

Key fault lines the evidence reveals:

**Definitions of “telehealth” differ by jurisdiction. **** Some payers reimburse only synchronous video visits; others include asynchronous messaging or remote monitoring. The scoping review documents that these definitional differences directly shape which services get paid for and which fall through the cracks.
Medicaid coverage is notoriously inconsistent. A national mystery-caller study on Medicaid access found that patients frequently receive inaccurate or conflicting information about what their coverage includes — a problem that compounds when telehealth-specific rules layer onto already-complex Medicaid structures.
Payment barriers become access barriers. Research on payment-related obstacles to opioid use disorder treatment found that reimbursement gaps cause patients to delay or abandon care entirely, a dynamic that applies broadly to any telehealth service in a coverage gray zone.
Low-resource settings face structural exclusion. A qualitative study from Ghana found that the absence of standardized reimbursement frameworks for mHealth-based telemedicine left implementers without sustainable funding models — a cautionary example of what happens when policy fails to keep pace with technology deployment.

For patients, the practical takeaway: never assume your telehealth visit is covered because telehealth in general is covered. Ask your insurer for the specific billing code, confirm whether your provider is in-network for virtual visits, and get coverage confirmation in writing before your appointment. The rules that apply to your neighbor may not apply to you.

This section is for general informational purposes only and does not constitute medical, legal, or financial advice. Consult a qualified healthcare professional and your insurance plan directly for guidance specific to your situation.

Who Gets Left Out: Medicaid, Marginalized Patients, and Coverage Gaps

**Medicaid patients face documented, systemic barriers to telehealth access — not because the technology doesn’t exist, but because reimbursement policies, provider participation rates, and structural gaps consistently leave the most vulnerable patients behind. ****

Telehealth’s promise of democratizing healthcare access collides with a fragmented reimbursement landscape. A scoping review of public reimbursement models across national and subnational jurisdictions found that coverage policies vary dramatically — between countries, states, and even between Medicaid managed care plans within the same state. For a low-income patient trying to determine whether a telehealth visit will be covered before booking, the system is functionally opaque.

The access gap is sharpest in specialized care. A national mystery caller study on Medicaid and orthopedic access (source) found that Medicaid patients were significantly less likely than privately insured patients to schedule appointments with specialized surgeons successfully. This disparity extends directly into telehealth specialty services, where provider participation in Medicaid remains inconsistent and often undisclosed upfront.

Patients managing addiction are among the hardest hit. A critical review of payment barriers to opioid use disorder medications (source) identified prior authorization requirements, coverage exclusions, and pharmacy-level restrictions as compounding obstacles — many of which persist in telehealth-delivered MOUD (medications for opioid use disorder) programs, where Medicaid reimbursement rules vary by state and modality.

Key structural gaps documented in the evidence:

Reimbursement parity is not universal. Many Medicaid programs reimburse telehealth visits at lower rates than in-person care or exclude certain visit types entirely, per the scoping review. **
Provider networks are thinner for Medicaid. The orthopedic access study confirms that Medicaid patients encounter more refusals and scheduling failures — a pattern that mirrors telehealth platform behavior when Medicaid is the payer.
Payment barriers compound clinical ones. For patients with opioid use disorder, payment-related obstacles don’t just delay care — they interrupt treatment continuity in ways that carry serious health consequences.

Telehealth platforms that market themselves as accessible and affordable without disclosing their Medicaid participation status or the specific services they will and won’t cover under public insurance deserve scrutiny. Patients should ask directly, in writing, before assuming coverage.

This section contains general health system and policy information only and does not constitute medical, legal, or financial advice. Consult a qualified healthcare professional and your insurance plan for guidance specific to your situation.

Telehealth’s Hidden Costs in Low-Resource Settings

Telehealth platforms marketed as affordable alternatives often carry high hidden costs for patients in low-resource settings — including data fees, device requirements, and out-of-pocket charges that insurers don’t cover — making the “accessible care” promise harder to deliver than advertisements suggest.

The gap between telehealth’s marketing and its financial reality is sharpest for patients who can least afford it. A qualitative study of the Akoma Pa mHealth-based telemedicine program in Ghana found that implementers identified coverage gaps, unclear pricing structures, and reimbursement uncertainty as core barriers to sustainable access — problems that patients rarely learn about until after enrollment (NCBI/PMID 42415045). These aren’t isolated cases; they reflect structural patterns in global telehealth financing.

A scoping review of public reimbursement models across national and subnational jurisdictions found that telehealth reimbursement frameworks vary dramatically, with many jurisdictions lacking consistent policies altogether, leaving patients exposed to unpredictable billing (NCBI/PMID 40794105). In practice, this means:

Patients may owe more than expected. Inconsistent or absent reimbursement rules can lead providers to bill patients directly for services they assumed were covered.
“Low-cost” platforms shift costs invisibly. Data charges, subscription tiers, and hardware requirements (smartphone, reliable broadband) are real expenses that don’t appear in advertised visit prices. **
Medicaid patients face compounding barriers. Research on Medicaid coverage and specialist access found that patients frequently encountered coverage confusion and denial when scheduling care — a pattern that extends to telehealth billing (NCBI/PMID 39637372). **
Payment barriers interrupt treatment continuity. A critical review of payment obstacles to medications for opioid use disorder found that financial friction — including unclear coverage — directly disrupted patient access to ongoing care (NCBI/PMID 38906417). The same dynamic applies to telehealth-delivered chronic condition management.

Patients in rural areas, those on fixed incomes, and those relying on public insurance are disproportionately affected. Before enrolling in any telehealth platform, request a written breakdown of all fees — including what your specific insurer will and will not cover — and verify that information directly with your plan, not through the platform’s customer service alone.

This section contains general health system and policy information for consumer awareness purposes only. It is not medical advice and does not constitute a diagnosis, treatment recommendation, or endorsement of any specific telehealth service. Consult a qualified healthcare professional for guidance specific to your situation.

When Payment Barriers Block Critical Care

Payment barriers in telehealth are not a minor inconvenience — they are a documented mechanism that delays or denies care for patients who are already underserved, particularly those seeking treatment for addiction, chronic conditions, and specialist services. The problem is structural, not accidental, and operates across insurance types, geographic regions, and care categories.

How the payment gap forms

Telehealth reimbursement rules vary dramatically by payer. A scoping review of public reimbursement models across national and subnational jurisdictions found that coverage policies differ not just between countries but between regions within the same country — meaning a patient’s zip code or plan type can determine whether a telehealth visit is covered at all, even when clinical need is identical.

Where patients feel it most

Addiction treatment: Payment obstacles are among the most consequential in opioid use disorder care. A critical review of payment-related barriers to medications for opioid use disorder found that prior authorization requirements, coverage gaps, and cost-sharing burdens directly obstruct access to evidence-based treatment — a finding with life-or-death implications for patients seeking telehealth-based prescribing.
Specialist access: Patients on Medicaid face compounding barriers. A national mystery caller study on Medicaid coverage found significant difficulty accessing specialized surgical care, with coverage uncertainty and appointment refusals creating obstacles that discourage patients from pursuing care. Telehealth does not automatically solve this — if reimbursement is denied, the platform is irrelevant.
Rehabilitation services: Even patients with coverage report confusion. A perceptions study among physical medicine and rehabilitation patients identified cost and insurance uncertainty as persistent barriers to telehealth adoption, even among those who had already used it.
Low-resource settings: A qualitative study of telemedicine implementation in Ghana found that pricing and reimbursement structures were among the primary implementation challenges — a reminder that payment design shapes access at every income level.

What patients should do

Before booking any telehealth appointment, verify in writing — not through a chatbot or marketing page — whether your insurer covers that visit type, provider, and diagnosis code. Ask for the CPT codes the provider will bill. If you are on Medicaid, call your plan directly; coverage varies by state and by managed care organization within the same state.

This section presents general health system information for consumer awareness purposes and does not constitute medical advice, diagnosis, or treatment recommendations. Consult a qualified healthcare professional for guidance specific to your situation.

What Investors See That Policymakers Are Missing

Investors are pouring capital into telehealth platforms precisely because reimbursement policy remains fragmented and inconsistent — a gap that creates pricing power for platforms and leaves patients exposed. While policymakers debate coverage rules, private capital is quietly locking in the infrastructure, patient relationships, and billing leverage that will shape telehealth economics for years.

Here is what the money is tracking that policy has not yet caught up to:

Reimbursement chaos is a feature, not a bug, for some platforms. A scoping review of public reimbursement models across national and subnational jurisdictions found that telehealth payment frameworks vary dramatically — even within single countries — leaving patients unable to predict costs or coverage. Platforms operating across multiple states or countries can exploit this inconsistency by routing patients toward higher-margin service lines where coverage rules are murkiest.
Senior health is a primary investment target. Research on strategic investment patterns in senior health documents that the medical industry is concentrating capital in older adult populations — a demographic with high utilization rates and, in many cases, limited ability to comparison-shop or challenge bills. Investors see a captive market; policymakers have not yet built consumer protections to match.
Payment barriers are already rationing care in high-need populations. A critical review of payment barriers to opioid use disorder treatment (source) found that prior authorization requirements, coverage gaps, and cost-sharing rules block access to medications for some of the most vulnerable patients — the same populations telehealth was supposed to reach. Investors see an addressable market; patients experience a locked door.
Policymakers are measuring the wrong outcomes. A qualitative study of telemedicine implementation in Ghana found that pricing and reimbursement structures were rarely designed with patient affordability as the primary variable — implementers prioritized platform sustainability over user cost protection. That priority ordering mirrors what U.S. investors reward.
Access gaps persist even when coverage nominally exists. A national mystery caller study on Medicaid and specialist access (source) found that having insurance coverage did not reliably translate into actual appointment access. This finding applies directly to telehealth, where listed providers may not accept a patient’s plan despite appearing in network directories.

The pattern is consistent: capital moves toward complexity and opacity because both generate margin. Patients navigating telehealth pricing today are operating in a market structured around investor return rather than care access.

This section contains general informational content and does not constitute medical advice, diagnosis, or treatment recommendations. Consult a qualified healthcare professional for guidance specific to your situation.

What Needs to Change: Key Findings and Watchdog Concerns

Telehealth’s most urgent problems are structural: inconsistent reimbursement rules, opaque pricing, and payment barriers that systematically exclude the most vulnerable patients from care. Until these gaps are addressed, telehealth’s promise of expanded access remains unevenly distributed.

Watchdog review of available evidence and public records identifies four areas demanding immediate attention from regulators, payers, and platforms:

1. Reimbursement rules vary widely — leaving patients unable to predict costs

No unified standard exists for telehealth visit costs or coverage. A scoping review of public reimbursement models across national and subnational jurisdictions found that coverage frameworks differ substantially even within single countries, preventing patients from anticipating out-of-pocket expenses before booking. This structural barrier disproportionately affects patients with chronic conditions who depend on telehealth for ongoing care.

2. Pricing opacity undermines patient trust and program sustainability

Implementers of telehealth programs consistently identify pricing transparency as a core operational failure. A qualitative study of telehealth implementers found that coverage and reimbursement ambiguity eroded both patient trust and program viability. Platforms advertising low-cost or “affordable” care without disclosing insurance limitations or visit-type exclusions warrant skepticism until fee schedules are published clearly and upfront.

3. Payment barriers actively block access for high-need populations

Patients seeking treatment for opioid use disorder face compounding payment obstacles. A critical review of payment-related barriers to medications for opioid use disorder found that insurance restrictions, prior authorization requirements, and cost-sharing rules create gaps between prescription and dispensing — gaps that telehealth platforms have not reliably closed.
Medicaid patients face particular access risks. A national mystery caller study found that Medicaid coverage status significantly predicted whether patients could schedule a specialist appointment, a dynamic that extends directly into telehealth scheduling and triage practices.

4. Patient and provider expectations diverge meaningfully

A study of physical medicine and rehabilitation patients and providers (source) found significant gaps between patient expectations and provider perceptions of telehealth visits — a mismatch affecting informed consent, satisfaction, and care continuity.

⚠️ Disclaimer: This section presents general informational findings drawn from published Research and is not medical advice. It does not constitute a diagnosis, treatment recommendation, or endorsement of any telehealth platform or service. Consult a qualified healthcare professional for guidance specific to your situation.

FAQ

Why does telehealth reimbursement vary so much between states and countries?

Research published in the Journal of Medical Internet Research found that public reimbursement models for telemedicine differ widely across national and subnational jurisdictions, reflecting a lack of coordinated policy frameworks. Factors such as local budget priorities, existing healthcare infrastructure, and political will all contribute to this inconsistency, leaving patients uncertain about what their insurance will actually cover.

Do Medicaid patients have equal access to telehealth services?

Evidence suggests they often do not. A national mystery-caller study in the Journal of the American Academy of Orthopedic Surgeons found that many specialized surgical practices refuse Medicaid patients. This barrier extends into virtual care settings. If providers do not accept Medicaid in person, they frequently do not accept it via telehealth either, undermining equity goals.

How do payment barriers affect people seeking treatment for opioid use disorder through telehealth?

A critical review in the Journal of Substance Use and Addiction Treatment identified payment-related obstacles as a major reason patients cannot initiate or maintain medications for opioid use disorder. Even when telehealth expands prescribing access, insurance denials, prior authorization requirements, and cost-sharing burdens can still prevent patients from filling prescriptions.

Are physical medicine and rehabilitation providers embracing telehealth despite insurance uncertainty?

Research in the American Journal of Physical Medicine & Rehabilitation found that both patients and providers hold mixed perceptions of telehealth, with insurance coverage uncertainty cited as a significant deterrent. Providers worry about reimbursement denials, and patients worry about unexpected bills, creating a chilling effect on adoption even when clinical suitability exists.

Can telehealth actually reduce healthcare costs for complex patients like those with dementia?

A secondary analysis of a randomized clinical trial published in JAMA Internal Medicine examined the Care Ecosystem Collaborative Model for Medicare beneficiaries with dementia and found potential cost implications worth monitoring. However, realizing savings depends heavily on whether reimbursement structures support ongoing virtual care coordination rather than one-off visits.

Is this content medical advice?

No. This report presents general health information sourced from peer-reviewed Research for educational purposes only. It is not medical advice, a diagnosis, or a treatment recommendation. Always consult a qualified healthcare professional for guidance specific to your health situation.

This article is for general information and is not medical, legal, or financial advice. Telehealth services, prescriptions, and insurance coverage vary by state and provider — verify a provider’s licensing and consult a qualified professional before making care decisions.